Idera Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Aceragen

10/08/2021 01:02

* Idera Pharmaceuticals Inc  IDRA.OQ  reported a quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Idera Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 15 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Idera Pharmaceuticals Inc shares had fallen by 11.7% this
quarter and lost 71.1% so far this year.
* The company reported a quarterly loss of $7.56 million.
* Wall Street's median 12-month price target for Idera
Pharmaceuticals Inc is $1.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 12:01 a.m.  ​All
figures in US dollars unless otherwise stated